These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37887384)

  • 1. The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery.
    Shen EY; U MRA; Cox IJ; Taylor-Robinson SD
    Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.
    Guo W; Tan HY; Wang N; Wang X; Feng Y
    Cancer Manag Res; 2018; 10():715-734. PubMed ID: 29692630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput Proteomics-Guided Biomarker Discovery of Hepatocellular Carcinoma.
    Shin D; Kim Y; Park J; Kim Y
    Biomed J; 2024 Jun; ():100752. PubMed ID: 38901798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
    Kim KH; Kim JY; Yoo JS
    Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
    Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
    J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
    Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
    BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.
    Wu X; Wang Z; Luo L; Shu D; Wang K
    Front Med Technol; 2022; 4():1065506. PubMed ID: 36688143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.
    Zeng J; Yin P; Tan Y; Dong L; Hu C; Huang Q; Lu X; Wang H; Xu G
    J Proteome Res; 2014 Jul; 13(7):3420-31. PubMed ID: 24853826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry.
    Chen S; Kong H; Lu X; Li Y; Yin P; Zeng Z; Xu G
    Anal Chem; 2013 Sep; 85(17):8326-33. PubMed ID: 23889541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
    Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients.
    Zeng J; Huang X; Zhou L; Tan Y; Hu C; Wang X; Niu J; Wang H; Lin X; Yin P
    Sci Rep; 2015 Nov; 5():16101. PubMed ID: 26526930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.
    Bowers J; Hughes E; Skill N; Maluccio M; Raftery D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():154-62. PubMed ID: 24666728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
    Nie W; Yan L; Lee YH; Guha C; Kurland IJ; Lu H
    Mass Spectrom Rev; 2016; 35(3):331-49. PubMed ID: 24890331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
    Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
    J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
    Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
    Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.
    Osman D; Ali O; Obada M; El-Mezayen H; El-Said H
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma.
    Abreu P; Ferreira R; Mineli V; Ribeiro MA; Ferreira FG; DE Mello Vianna RM; Tomasich FDS; Szutan LA
    Anticancer Res; 2020 Dec; 40(12):6573-6784. PubMed ID: 33288552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.